Inventor · disambiguated record
Bernd Henkel
Also filed as: HENKEL BERND
19 granted patents·3 pending applications·111 citations·filing 2003–2019
92Inventor score
Top patents by PatentIndex Score
22 records- 0191US9181305B2Exendin-4 peptide analoguesSANOFI SA·Filed 2013·Granted Nov 10, 2015·19 cites·44 claims
- 0290US9745360B2Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonistsSANOFI SA·Filed 2013·Granted Aug 29, 2017·14 cites·36 claims
- 0388US9750788B2Non-acylated exendin-4 peptide analoguesSANOFI SA·Filed 2014·Granted Sep 5, 2017·11 cites·23 claims
- 0487US9365632B2Exendin-4 derivatives as dual GLP1/glucagon agonistsSANOFI SA·Filed 2013·Granted Jun 14, 2016·9 cites·38 claims
- 0584US7816377B2Tubulysin analoguesR & D BIOPHARMACEUTICALS GMBH·Filed 2003·Granted Oct 19, 2010·42 cites·17 claims
- 0680US9789165B2Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonistsSANOFI SA·Filed 2014·Granted Oct 17, 2017·4 cites·23 claims
- 0780US9751926B2Dual GLP-1/GIP receptor agonistsSANOFI SA·Filed 2014·Granted Sep 5, 2017·4 cites·27 claims
- 0879US9694053B2Dual GLP-1/glucagon receptor agonistsSANOFI SA·Filed 2014·Granted Jul 4, 2017·4 cites·22 claims
- 0976US9982029B2Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonistsSANOFI SA·Filed 2016·Granted May 29, 2018·2 cites·34 claims
- 1076US9670261B2Functionalized exendin-4 derivativesSANOFI SA·Filed 2013·Granted Jun 6, 2017·2 cites·49 claims
- 1155US10758592B2Exendin-4 derivatives as dual GLP1/glucagon agonistsSANOFI SA·Filed 2017·Granted Sep 1, 2020·0 cites·23 claims
- 1254US10253079B2Functionalized Exendin-4 derivativesSANOFI SA·Filed 2017·Granted Apr 9, 2019·0 cites·30 claims
- 1353US10450343B2Synthesis of cyclic imide containing peptide productsSANOFI AVENTIS DEUTSCHLAND·Filed 2014·Granted Oct 22, 2019·0 cites·18 claims
- 1450US11028123B2Capping of unprotected amino groups during peptide synthesisSANOFI AVENTIS DEUTSCHLAND·Filed 2019·Granted Jun 8, 2021·0 cites·21 claims
- 1550US2016220643A1Exendin-4 derivatives as dual glp1/glucagon agonistsSANOFI SA·Filed 2016·Application pending·0 cites
- 1648US10087221B2Synthesis of hydantoin containing peptide productsSANOFI AVENTIS DEUTSCHLAND·Filed 2014·Granted Oct 2, 2018·0 cites·10 claims
- 1747US11560402B2Method for cleavage of solid phase-bound peptides from the solid phaseSANOFI AVENTIS DEUTSCHLAND·Filed 2019·Granted Jan 24, 2023·0 cites·15 claims
- 1846US2015166625A1Exendin-4 Peptide AnaloguesSANOFI SA·Filed 2014·Application pending·0 cites
- 1946US2017022260A9Exendin-4 peptide analogues as dual glp-1/glucagon receptor agonistsSANOFI SA·Filed 2014·Application pending·0 cites
- 2044US7807710B2Macrocycles for the treatment of cancerR & D BIOPHARMACEUTICALS GMBH·Filed 2004·Granted Oct 5, 2010·0 cites·12 claims
- 2137US11021512B2Method of preparing peptides comprising a lipophilically modified lysine side chainSANOFI SA·Filed 2017·Granted Jun 1, 2021·0 cites·24 claims
- 2237US9932381B2Exendin-4 derivatives as selective glucagon receptor agonistsSANOFI SA·Filed 2015·Granted Apr 3, 2018·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Bernd Henkel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →